Company Profile
Alchemab Therapeutics Ltd
12156844•Private Limited With Share Capital
Get Full Access
14/08/2019
7 years
7
55
72110
very low risk
Company Overview
Registration, classification & business activity
Alchemab Therapeutics Ltd (12156844) is a private limited with share capital incorporated on 14/08/2019 (7 years old) and registered in london, N1C4AX. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. alchemab takes an unbiased and function-first approach using three complementary processes and cutting-e...
Financial Overview
£55.5K
£32.4K
£23.1K
£30.0K
£44.5K
Key Metrics
55
Employees
7
Directors
53
Shareholders
25
Patents
Board of Directors
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Innovate Grants
This company received a grant of £988266.0 for Novel Protective 'Self'-Antibodies For Disease Modification In Huntington’S Disease. The project started on 01/03/2021 and ended on 31/10/2022.
This company received a grant of £1350188.0 for Pre-Clinical Development Of Novel ‘Self’-Antibodies For Disease Modification In Huntington’S Disease. The project started on 01/12/2022 and ended on 28/02/2025.
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating